Nov. 3, 2015 "We achieved positive pre-clinical animal data for...

Nov. 3, 2015
"We achieved positive pre-clinical animal data for pulmonary hypertension, initial echocardiography and neurohormonal clinical data pointing to neuromodulation as a mechanism for potential myocardial recovery"

"The Company conducted a pre-clinical pulmonary artery hypertension study at Jewish Hospital in Louisville, Kentucky under the guidance of Dr. Mark Slaughter. This acute animal study demonstrated a profound impact in reducing pulmonary hypertension in the animals. Additional pre-clinical studies are planned in the fourth quarter of 2015."

No mention in 4 th quarter release Mar 3, 2016 , does this mean they have stopped this study due to funding or it failed.